- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/205 - Radicals derived from carbonic acid
Patent holdings for IPC class C07D 295/205
Total number of patents in this class: 178
10-year publication summary
|
15
|
19
|
15
|
15
|
11
|
14
|
15
|
9
|
7
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| H. Lundbeck A/S | 1231 |
12 |
| Abide Therapeutics, Inc. | 26 |
7 |
| Amgen Inc. | 4425 |
5 |
| The Regents of the University of California | 20720 |
4 |
| FUJIFILM Corporation | 30512 |
4 |
| The Scripps Research Institute | 1343 |
4 |
| Arvinas Operations, Inc. | 261 |
4 |
| Noramco, LLC | 28 |
4 |
| Nxera Pharma UK Limited | 188 |
4 |
| Janssen Pharmaceutica N.V. | 3171 |
3 |
| Sumitomo Chemical Company, Limited | 8996 |
3 |
| Mitsui Chemicals, Inc. | 3242 |
3 |
| Dongguk University Industry-Academic Cooperation Foundation | 480 |
3 |
| Korea University Research and Business Foundation | 3262 |
3 |
| Metabolys | 7 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 406 |
3 |
| Libra Therapeutics, Inc. | 10 |
3 |
| Pyrotech (Beijing) Biotechnology Co., Ltd. | 12 |
3 |
| Tianjin Gudui Bio-Pharm Co., Ltd. | 7 |
3 |
| AstraZeneca AB | 2818 |
2 |
| Other owners | 98 |